Tonghe Pharmaceutical (300636.SZ): The API agomelatine complies with GMP

Zhitongcaijing · 01/07 12:41

Zhitong Finance App News, Tonghe Pharmaceutical (300636.SZ) announced that the company recently received the “Jiangxi Drug Administration Drug GMP Compliance Inspection Results Notice” from the Jiangxi Drug Administration. It was learned that after on-site inspection and comprehensive assessment, the company tested that the active ingredient agomelatine was in line with the GMP drug. Agomelatine is indicated for treating depression in adults.